Next week's SP, page-20

Hey @Liebherr ,
I posted this a while back about the conference:

https://hotcopper.com.au/posts/36216931/single







This is not a medical conference, presenting scientific research to the biotech community...

This event is entirely focused on bringing biotech companies together with investors. If you follow the Investor Pass link you get this:

Investor passes are reserved solely for qualified institutional and venture investors whose primary activity is direct investment in research and development companies. Qualified categories include private equity, commodity traders, asset management, investment management, hedge funds, sovereign wealth funds, venture capital, private wealth manager, family office, mutual fund, pension fund, SOE, private investors and HNWI.Event attendance is also complimentary for qualified executives from local and international pharmaceutical companies

Hence, the significance of this event should not be under estimated IMO.

Hope this helps.

Cheers
MSN